“…Additionally, in the NSCLC microenvironment, tumor-derived TGF-β can also increase miR-183, which can decrease DNAX activating protein 12 kDa (DAP12) (a protein required for NK cell cytotoxicity functions), ultimately inhibiting tumor-infiltrating NK cell activities to promote immunosuppression [140], while miRNAs and lncRNAs can also exhibit opposite effects on lung cancer metastasis. MiR-132 [77], miR-203, miR-145 [78], miR-205 [79], miR-124 [80], miR-422a [17], miR-196b [82], miR-940 [83], miR-22 [84], miR-200a, miR-200c [85,86], miR-145, miR-497 [87], miR-149 [88], miR-134 [89], miR-133 [90], miR-29c [91], miR-16 [94], miR-129 [96], miR-485-5p [97], miR-3127-5p [98], and LINP1 [121] can suppress TGF-β signaling-regulated EMT. MiR-3607-3p [99], miR-206, miR-140 [100], miR-136 [102], miR-133a [103], miR-143 [104], miR-886-3p [105], HAND2-AS1 [119], linc01186 [120], ANCR [122], and NKILA [123] can repress TGF-β signaling-modulated lung cancer cell migration and invasion.…”